DNA mismatch repair and Chk1-dependent centrosome amplification in response to DNA alkylation damage

被引:22
作者
Robinson, Helen M. R.
Black, Elizabeth J.
Brown, Robert
Gillespie, David A. F.
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Glasgow, Beatson Labs, CRUK Ctr Oncol & Appl Pharmacol, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
关键词
cell cycle checkpoints; cell death; centrosome; DNA MMR;
D O I
10.4161/cc.6.8.4111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Centrosome amplification is frequently observed in tumor cells exposed to genotoxic stress, however the underlying mechanisms and biological consequences are poorly understood. Here, we show that the anti - metabolite and alkylating agent 6 - thioguanine ( 6 - TG) induces centrosome amplification resulting in the formation of multi - polar spindles when damaged cells subsequently enter mitosis. These aberrant, multi - polar mitoses are frequently resolved by asymmetric cell divisions causing unequal segregation of genetic material and cell death in one or both daughter products. We show that this phenomenon is associated with transient cell cycle delay in S - and G(2) - phase and is dependent on DNA mismatch repair ( DNA MMR) proficiency and Chk1 protein kinase activity. Although Chk1 - deficient cells do not exhibit cell cycle delay, centrosome amplification, or multi - polar spindle formation, continued cell cycle progression in the presence of 6 - TG eventually results in increased levels of mitotic catastrophe, most probably due to mitosis with incompletely replicated DNA. Taken together, these results reveal novel mechanisms of cell killing by 6 - TG and underscore the importance of interactions between cell cycle checkpoints and DNA MMR in determining the fate of cells bearing DNA damage.
引用
收藏
页码:982 / 992
页数:11
相关论文
共 24 条
  • [11] Hirose Y, 2001, CANCER RES, V61, P5843
  • [12] The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents
    Hirose, Y
    Katayama, M
    Stokoe, D
    Haas-Kogan, DA
    Berger, MS
    Pieper, RO
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (22) : 8306 - 8315
  • [13] Hirose Y, 2001, CANCER RES, V61, P1957
  • [14] Inamochi H, 1999, J EXP CLIN CANC RES, V18, P417
  • [15] Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase
    Krämer, A
    Mailand, N
    Lukas, C
    Syljuåsen, RG
    Wilkinson, CJ
    Nigg, EA
    Bartek, J
    Lukas, J
    [J]. NATURE CELL BIOLOGY, 2004, 6 (09) : 884 - U71
  • [16] Checking out the centrosome
    Krämer, A
    Lukas, J
    Bartek, J
    [J]. CELL CYCLE, 2004, 3 (11) : 1390 - 1393
  • [17] Structure meets function -: Centrosomes, genome maintenance and the DNA damage response
    Loeffler, Harald
    Lukas, Jiri
    Bartek, Jiri
    Kraemer, Alwin
    [J]. EXPERIMENTAL CELL RESEARCH, 2006, 312 (14) : 2633 - 2640
  • [18] Signalling cell cycle arrest and cell death through the MMR System
    O'Brien, V
    Brown, R
    [J]. CARCINOGENESIS, 2006, 27 (04) : 682 - 692
  • [19] Mismatch repair and DNA damage signalling
    Stojic, L
    Brun, R
    Jiricny, J
    [J]. DNA REPAIR, 2004, 3 (8-9) : 1091 - 1101
  • [20] Mismatch repair-dependent G2 checkpoint induced by low doses Of SN1 type methylating agents requires the ATR kinase
    Stojic, L
    Mojas, N
    Cejka, P
    di Pietro, M
    Ferrari, S
    Marra, G
    Jiricny, J
    [J]. GENES & DEVELOPMENT, 2004, 18 (11) : 1331 - 1344